Developing Targeted Therapies in Low-Frequency Molecular Subsets of a Disease
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 16, 2018
April 9, 2024
becd1349-aa73-4de3-83cd-a43abfb0f98c
Related Documents
Physiologically Based Pharmacokinetic Analyses — Format and Content Guidance for Industry
Guidance DocumentSeptember 4, 2018Center for Drug Evaluation and Research
Duchenne Muscular Dystrophy and Related Dystrophinopathies: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentFebruary 16, 2018Center for Drug Evaluation and Research
Migraine: Developing Drugs for Acute Treatment
Guidance DocumentFebruary 16, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox